Cardioprotective activity of endogenous and exogenous nitric oxide on ischaemia reperfusion injury in isolated guinea pig hearts

Inflammation Research

Volumn 48, Issue 11, 1999, Pages 561-568

  Masini, E ^a   Salvemini, D ^b   Ndisang, J F ^a   Gai, P ^a   Berni, L ^a   Moncini, M ^a   Bianchi, S ^c   Mannaioni, P F ^a  

^a Dept of Preclinical Pharmacology ^*  (Italy)

^b PFIZER INC   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Anion; Histamine; Ischaemia reperfusion; Nitric oxide superoxide; NO donors

Indexed keywords

ARGININE; CALCIUM; DEXTRO ARGININE; GLYCERYL TRINITRATE; HISTAMINE; LACTATE DEHYDROGENASE; LINSIDOMINE; MALONALDEHYDE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; NITROPRUSSIDE SODIUM; SUPEROXIDE DISMUTASE; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; GUINEA PIG; HEART PROTECTION; HISTAMINE RELEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID PEROXIDATION; MALE; MAST CELL DEGRANULATION; NONHUMAN; REPERFUSION INJURY;

ANIMALS; ARGININE; ARRHYTHMIA; CALCIUM; CELL DEGRANULATION; CORONARY VESSELS; ENZYME INHIBITORS; GUINEA PIGS; HISTAMINE RELEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; LIPID PEROXIDATION; MALE; MAST CELLS; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; REPERFUSION INJURY; VASODILATOR AGENTS;

EID: 0032695619     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050504     Document Type: Article

References (57)

1. Lefer AM, Tsao PS, Lefer DJ, Ma X-I. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991; 5: 2029-34.
2. Koster JF, Biemond P, Stam H. Lipid peroxidation and myocardial damage: Cause or consequence? In: Stam H, Van Der Vusse GJ, editors. Lipid Metabolism in the Normoxic and Ischemic Heart. Darmstadt: Steinkhoff, Verlag, 1986: 253-60.
3. Xie YW, Wolin MS. Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Involvement in response to hypoxia/reoxygenation. Circulation 1996; 94: 2580-6.
4. Keller AM, Clancy RM, Barr ML, Marbol CC, Connors PJ. Acute reoxygenation injury in isolated rat heart: Role of resident cardiac mast cells. Circ Res 1988; 63: 1044-52.
5. Rydzynski K, Dalen H, Sactersdal T, Engedal H. Morphological and morphometric analysis of the mast cells from human heart biopsies. Agents Actions 1987; 20: 288-90.
6. Wolff AA, Levi R, Fischer VJ, Chenooda AA. Cardiac histamine release and ventricular arrhythmias after coronary occlusion in the dog. Fed Proc 1984; 43: 458.
7. Masini E, Planchenault J, Pezziardi F, Gautier P, Gagnol JP. Histamine release during an experimental coronary thrombosis in awake dog. Agents Actions 1985; 16: 227-30.
8. Salvemini D, Masini E, Anggárd E, Mannaioni PF, Vane JR. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: Stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem Biophys Res Commun 1990; 169: 596-601.
9. Salvemini D, Masini E, Pistelli A, Mannaioni PF, Vane JR. Nitric oxide: A regulatory mediator of mast cells reactivity. J Cardiovasc Pharmacol 1991; 17: 258-64.
10. Liu P, Hock CE, Nagele R, Wong PY. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol 1997; 272: H2327-36.
11. Azuma H, Ischikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 88: 411-4.
12. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181-7.
13. Radomski MW, Palmer RMJ, Moncada S. The anti-aggregating properties of vascular endothclium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987b; 92: 639-46.
14. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; ii: 1057-8.
15. Sneddon JM, Vane JR. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1987; 185: 2800-4.
16. Rubanyi JM, Vanhoutte PM. Superoxide anions and hyperoxia in activated endothelium-derived relaxing factor. Am J Physiol 1986; 250: 222-7.
17. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of the endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br J Pharmacol 1986; 87: 685-94.
18. Kupatt C, Zahler S, Seligmann C, Massoudy P, Becker BF, Gerlach E. Nitric oxide mitigates leukocyte adhesion and vascular leak after myocardial ischemia. J Mol Cell Cardiol 1996; 28: 643-54.
19. Salvemini D, Misko TP, Masferrer JM, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1996; 90: 7240-4.
20. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
21. Lefer AM, Lefer DJ. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 1993; 33: 71-90.
22. Johnson G, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991; 19: 244-52.
23. Nakanishi K, Vinten-Johansen J, Lefer DJ, Zhao Z, Fowler WC, McGee DS, Johnston WE. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 1992; 263: H6501-58.
24. Lefer AM. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy. Ann Thorac Surg 1995; 60: 847-51.
25. Masini E, Gambassi F, Bianchi S, Mugnai L, Lupini M, Pistelli A, et al. Effect of nitric oxide generators on ischemia-reperfusion injury and histamine release in isolated perfused guinea pig heart. Int Arch Allergy Appl Immunol 1991; 94: 257-8.
26. Shore PA, Burkhalter A, Cohn VH. A method for the fluorimetric assay of histamine in tissues. J Pharmacol Exp Ther 1959; 127: 182-6.
27. Lorenz W, Reimann HJ, Barth H, Kusche J, Meyer R, Doenicke A, Hutzel M. A sensitive and specific method for the determination of histamine in human whole blood and plasma. Hoppe-Seyler's Z Physiol Chem 1972; 353: 911-20.
28. Bergmeyer HU, Bernt E. Lactate dehydrogenase UV-assay with pyruvate and NADH. In: Bergmeyer HU, editor. Methods for Enzymatic Analysis. New York: Verlag Chemie, Academic Press, 1974: 574-9.
29. Salvemini D, Mollace V, Pistelli A, Änggård E, Vane JR. Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1992; 89: 982-6.
30. Dahle LK, Hill EG, Hohnan RT. The thiobarbituric acid reaction and the autoxidation of polyunsatured fatty acid methyl ester. Arch Biochem 1962; 98: 253-61.
31. Ohkawa H, Onishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analyt Biochem 1979; 85: 351-8.
32. Masini E, Bianchi S, Gambassi F, Palmerani B, Pistelli A, et al. Ischemia reperfusion injury and histamine release in isolated and perfused guinea-pig heart: Pharmacological interventions. Agents Actions 1990; 30: 198-201.
33. Bianchi S, Mugnai L. Mast cell fixation and staining in image analysis. Eur J Basic Appl Istochem 1991; 35: 161-74.
34. Bani Sacchi T, Barattini M, Bianchi S, Blandina P, Brunelleschi S, Fantozzi R, el al. The release of histamine by parasympathetic stimulation in guinea pig auricle and rat ileum. J Physiol 1986; 371: 29-43.
35. Lowry OM, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
36. Dietrich HA, Loffelholz K, Pompetzki H. Acetylcholine overflow from isolated perfused hearts of various species in the absence of cholinesterase inhibition. Naunyn-Schmiedeberg's Arch Pharmacol 1977; 296: 149-52.
37. Pabla R, Curtis MJ. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart. J Mol Cell Cardiol 1996; 28: 2111-21.
38. Austen KF. The heterogeneity of mast cell populations and products. Hosp Pract 1984; 19: 135-43.
39. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol Today 1992; 13: 93-100.
40. Parratt J. Endogenous myocardial protective (antiarrhythmic) substances. Cardiovasc Res 1993; 27: 693-702.
41. Mannaioni PF, Masini F., Pistelli A, Salvemini D, Vane JR. Mast cells as a source of superoxide anions and nitric oxide-like factor: Relevance to histamine release. Int J Tiss React 1991; 13: 271-8.
42. Dai S. Effect of SK & F 93479 on experimentally induced ventricular arrhythmias in dogs, rats and mice. Agents Actions 1984; 15: 131-6.
43. Dai S. Effects of ranitidine and cimetidine on experimentally induced ventricular arrhythmias in anaesthetized rats. Agents Actions 1985; 17: 460-5.
44. Mullane KM. Myocardial ischemia-reperfusion injury: Role of neutrophils and neutrophil derived mediators. In: Marone G, editor. Current Concepts in Immunology. Clinical Immunology, Human Inflammatory Disease. Vol. I. Burlington, ON: Decker, 1988: 143-59.
45. Liu P, Hock CE, Nagele R, Wong PY. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol 1997; 272: H2327-36.
46. Rubanyi JM, Ho EH, Cantor EA, Lum WC, Botelho LHP. Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 1991; 281: 1392-7.
47. Mannaioni PF, Masini E. The release of histamine by free radicals. Free Radical Biol Med 1988; 5: 177-97.
48. Salvemini D, De Nucci G, Sneddon JM, Vane JR. Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol 1989; 97: 1145-50.
49. Salvemini D, De Nucci G, Vane JR. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation. A comparative study in washed platelets and platelet rich plasma. Thromb Haemostas 1991; 65: 421-4.
50. McCord JM. Oxygen derived free radicals in post-ischemic tissue injury. N Engl J Med 1985; 312: 163-9.
51. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Circ Res 1986; 58: 331-40.
52. Downly JM. Free radicals and their involvement during long term myocardial ischemia and reperfusion. Am Rev Physiol 1990; 5: 487-504.
53. Ambrosio G, Flaherty JT, Duilio C, Tritto I, Santoro G, Elia PP, et al. Oxygen radicals generated heart reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 1991; 87: 2056-66.
54. Suzuki S, Kaneko M, Chapman DC, Dahl NS. Alterations in cardiac contractile proteins due to oxygen free radicals. Biochem Biophys Acta 1991; 1074: 95-100.
55. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen spccies. Proe Natl Acad Sci USA 1993; 90: 9813-7.
56. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
57. Williams MW, Taft CS, Ramnauth S, Zhao ZQ, Vinten-Johansen J. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res 1995; 30: 79-86.